Delivery Order SPE2DB25D3018-SPE2DB25FUYCD
- Not listed
- The Defense Logistics Agency awarded a $4,521.27 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,416.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract valued through December 2026. The place of...
- The Defense Logistics Agency awarded a $4,373.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens with a July 28, 2025 completion date. This non-set-aside award represents a single delivery order under AmerisourceBergen's broader contract vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Trulicity 0.75 mg/0.5 mL pens on July 24, 2025. The contract, valued at $1,889.60 with a firm fixed price structure, represents a single delivery order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was competitively made with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $6,354.48 under a firm fixed-price contract. This non-set-aside delivery order, which is due for completion by July 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a $4,013.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. The contract, which is classified as a child contract with an ultimate completion date of July 21, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $4,524.48 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYCDDelivery Order
The Defense Logistics Agency awarded a $4,881.77 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Trulicity, a diabetes medication, represents one of the broad range of pharmaceutical products the company supplies through its federal contract portfolio to support military and veteran healthcare systems. This delivery order is a child contract executed under AmerisourceBergen's comprehensive DLA IDC valued at $999,999,999.00 and running through December 2026, which serves as the global pharmaceutical support vehicle for the Defense Health Agency and other federal healthcare programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that maintains a significant federal contract portfolio with DLA, delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military medical supply chains worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/29/25 |